President TrumpDonald John TrumpPelosi plans to present a fourth Coronavirus Relief Bill in late April to provide 1 million surgical masks to key New York employees. Private equity firms linked to Kushner are calling on the Trump administration to relax the rules for the loan program: READ MORE Health officials have been pushing to provide antimalarial medication as a coronavirus treatment, although the treatment of COVID-1
The president urged senior officials from the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA) and the National Institute of Health (NIH) to focus on cloroquine and hydroxychloroquine as possible treatments, the two sources said.
In response to pressure from the president, the federal government issued guidelines stating that doctors had the option to prescribe these drugs and cited undeclared anecdotes instead of the usual science-tested science.
The White House said in a statement to Reuters that Trump did not launch a “print campaign” but took appropriate action.
“The President’s top priority is the health and safety of the American people, which is why he has brought the federal government and the private sector, including doctors, scientists, and medical researchers, together in an unprecedented manner to drive vaccine development,” the statement said .
The CDC informed Reuters that it had published the guidelines at the request of the Coronavirus Task Force and doctors who “asked the CDC to review the literature, to write and publish the information as soon as possible”.
“The agency has,” says the statement.
A NIH spokeswoman said the agency was “not the source of the content.”
The guidelines said they were reviewed by the National Center for Immunization and Respiratory Diseases (NCIRD) of the CDC’s Department of Viral Diseases.
The FDA said in a statement to Reuters that it had acted correctly when it placed an emergency order for the prescription and distribution of the malaria medication.
“Based on the available scientific evidence, it has been determined that it is reasonable to believe that the specific drugs can be effective in the treatment of COVID-19 and that there are no adequate, approved or available alternative treatments for the known ones and The potential benefits for treating this serious or life-threatening virus outweigh the known and potential risks, ”the FDA statement said.
Trump has expressed support for the drugs, especially on his Twitter. Its advocates say they approve the use of the medication in a pandemic because there is no proven treatment for COVID-19.
However, research has shown that certain people taking the medication may experience an interrupted heartbeat or an irregular heartbeat and that the medication can “pose a particular risk to seriously ill people,” according to Reuters.